Mymd Pharmaceuticals Inc (MYMD)
Sector • Healthcare Industry • In Vitro & In Vivo Diagnostic Substances |
Industry • In Vitro & In Vivo Diagnostic Substances |
Sector • Healthcare |
News
Mymd Pharmaceuticals Inc*s Troubling Third Quarter Earnings: A Bumpy Ride for Investors
Between many companies, the MYMD announced as well its fourth quarter of 2022 effort
As one of many corporations, the MYMD disclosed also the second quarter of 2022 performance
The company announced operating loss in the first quarter of 2022
Between many corporations, the MYMD reported as well its fourth quarter of 2021 effort